Cargando…

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

BACKGROUND/AIMS: Fatty liver disease is defined as a cluster of diseases with heterogeneous etiologies, and its definition continues to evolve. The novel conceptional criteria for metabolic dysfunction-associated fatty liver disease (MAFLD) were proposed in 2020 to avoid the exclusion of a certain s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shang-Chin, Su, Hau-Jyun, Kao, Jia-Horng, Tseng, Tai-Chung, Yang, Hung-Chih, Su, Tung-Hung, Chen, Pei-Jer, Liu, Chun-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129653/ https://www.ncbi.nlm.nih.gov/pubmed/33431715 http://dx.doi.org/10.5009/gnl20218

Ejemplares similares

Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2023)

Direct comparison of biopsy techniques for hepatic malignancies
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
por: Su, Tung-Hung, et al.
Publicado: (2013)

Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020)

The clinical and histological characteristics of patients with biopsy-proven non-alcoholic fatty liver disease in the absence of insulin resistance
por: Demirtas, Coskun Ozer, et al.
Publicado: (2020)

Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis
por: Wu, Hsin-Yun, et al.
Publicado: (2023)

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
por: Tsai, Ming-Chao, et al.
Publicado: (2020)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Host Genetic Factors Affecting Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients
por: Cheng, Huei-Ru, et al.
Publicado: (2013)

Correction: Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease
por: Lin, Meng-Ju, et al.
Publicado: (2023)

Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease
por: Sekulic, Miroslav, et al.
Publicado: (2017)

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection
por: Yang, Wan-Ting, et al.
Publicado: (2016)

The clinical manifestations and management of COVID-19-related liver injury
por: Su, Tung-Hung, et al.
Publicado: (2020)

Endosonographic Features of Histologically Proven Gastric Ectopic Pancreas
por: Chou, Jen-Wei, et al.
Publicado: (2014)

Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Chen, George, et al.
Publicado: (2023)

Prognostic Value of the Alcoholic Hepatitis Histologic Score in Korean Patients with Biopsy-Proven Alcoholic Hepatitis
por: Lee, Dong Hyeon, et al.
Publicado: (2020)

Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
por: Alsaif, Faisal A., et al.
Publicado: (2020)

Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
por: Su, Tung-Hung, et al.
Publicado: (2012)

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019)

Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2017)

Confocal Microscopy in Biopsy Proven Argyrosis
por: Palamar, Melis, et al.
Publicado: (2013)

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress
por: Carpino, Guido, et al.
Publicado: (2017)

Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters
por: Lin, Su-Ru, et al.
Publicado: (2021)

Clinical study of histologically proven conjunctival cysts
por: Thatte, Shreya, et al.
Publicado: (2015)

Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
por: Wu, Jer-Wei, et al.
Publicado: (2021)

Negative Biopsy after Referral for Biopsy-Proven Gastric Cancer
por: Tae, Chung Hyun, et al.
Publicado: (2016)

Peginterferon plus Ribavirin for HIV-infected Patients with Treatment-Naïve Acute or Chronic HCV Infection in Taiwan: A Prospective Cohort Study
por: Liu, Chen-Hua, et al.
Publicado: (2015)

Patterns of biopsy-proven renal diseases in geriatric patients: A single medical center experience
por: Huang, Yung-Chieh, et al.
Publicado: (2022)

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model
por: Li, Yung-Tsung, et al.
Publicado: (2016)

The spectrum of biopsy-proven renal diseases in Korea
por: Lim, Beom Jin
Publicado: (2020)

Malignant Degeneration of Biopsy-Proven Hamartoma to Chondrosarcoma
por: Schenkel, Rachel, et al.
Publicado: (2020)

Electroanatomical features of biopsy-proven cardiac amyloidosis
por: Casella, M, et al.
Publicado: (2023)

Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
por: Liu, Chen-Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cij8gl467jvc5na0qlun07hufj